1990
A prospective comparison of neuropsychologic function in HIV-seropositive and seronegative methadone-maintained patients
McKegney F, O'Dowd M, Feiner C, Selwyn P, Drucker E, Friedland G. A prospective comparison of neuropsychologic function in HIV-seropositive and seronegative methadone-maintained patients. AIDS 1990, 4: 565-570. PMID: 2386618, DOI: 10.1097/00002030-199006000-00011.Peer-Reviewed Original ResearchConceptsPsychological Screening TestMethadone clinic patientsMethadone-maintained populationsEvidence of HIVMethadone-maintained patientsDigit spanProspective longitudinal studyPsychosocial functioningNeuropsychologic functionRace/ethnicityPsychosocial assessmentCognitive impairmentHIV antibodiesHIV infectionLongitudinal studyUnivariate analysisMean intervalProspective comparisonSerological testingSerological statusPhysical symptomsDrug useBaseline testingScreening testSeropositives
1989
Risk Factors for Human Immunodeficiency Virus Infection in Intravenous Drug Users
Schoenbaum E, Hartel D, Selwyn P, Klein R, Davenny K, Rogers M, Feiner C, Friedland G. Risk Factors for Human Immunodeficiency Virus Infection in Intravenous Drug Users. New England Journal Of Medicine 1989, 321: 874-879. PMID: 2770823, DOI: 10.1056/nejm198909283211306.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virus (HIV) infectionImmunodeficiency virus infectionIntravenous drug usersPercentage of injectionsRisk factorsHIV antibodiesDrug usersIntravenous drugsVirus infectionSex partnersSeroprevalence of HIVIndependent risk factorOnly risk factorMethadone treatment programsNumber of injectionsNon-Hispanic whitesHeterosexual sex partnersHIV infectionLast injectionUsed needlesHigh seroprevalenceDrug useShooting galleriesHIVInfection